DAHLE MEDICAL AS

2619 LILLEHAMMER

Finances

Return on Equity

16,71 %

Current Ratio

2,29

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	103 808 000	121 558 000	124 221 000	98 591 000
Net Income	4 363 000	16 507 000	18 933 000	6 706 000
Total Assets	44 484 000	59 737 000	59 257 000	39 277 000
Total Equity	26 112 000	25 259 000	22 012 000	17 120 000

Income (NOK)	2022	2021	2020	2019
Revenue	103 808 000	121 558 000	124 221 000	98 591 000
Expenditure	98 245 000	100 492 000	99 981 000	89 971 000
Operating Profit	5 564 000	21 066 000	24 240 000	8 620 000
Financial Income	99 000	403 000	651 000	89 000
Financial Costs	69 000	305 000	616 000	111 000
Financial Balance	30 000	98 000	35 000	−22 000
Earnings Before Tax	5 594 000	21 165 000	24 276 000	8 599 000
Tax	1 231 000	4 657 000	5 343 000	1 893 000
Net Income	4 363 000	16 507 000	18 933 000	6 706 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	2 385 000	2 274 000	2 141 000	1 648 000
Total Current Assets	42 100 000	57 463 000	57 116 000	37 629 000
Total Assets	44 484 000	59 737 000	59 257 000	39 277 000
Total Retained Equity	15 502 000	14 649 000	11 402 000	6 509 000
Total Equity	26 112 000	25 259 000	22 012 000	17 120 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	18 372 000	34 477 000	37 245 000	22 157 000
Total Equity and Debt	44 484 000	59 737 000	59 257 000	39 277 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	103 807 000	121 450 000	124 146 000	98 584 000
Other Income	1 000	108 000	76 000	7 000
Revenue	103 808 000	121 558 000	124 221 000	98 591 000
Cost of Goods Sold	65 850 000	70 180 000	72 423 000	63 503 000
Salary Costs	17 960 000	17 201 000	16 019 000	15 776 000
Depreciation	456 000	435 000	362 000	285 000
Impairment	0	0	0	0
Expenditure	98 245 000	100 492 000	99 981 000	89 971 000
Operating Profit	5 564 000	21 066 000	24 240 000	8 620 000
Financial Income	99 000	403 000	651 000	89 000
Financial Costs	69 000	305 000	616 000	111 000
Financial Balance	30 000	98 000	35 000	−22 000
Dividends	0	0	0	0
Net Income	4 363 000	16 507 000	18 933 000	6 706 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	516 000	649 000	729 000	651 000
Real Eastate	347 000	137 000	0	0
Machinery and Plant Facilities	40 000	0	0	0
Fixtures	876 000	883 000	807 000	492 000
Total Tangible Assets	1 263 000	1 020 000	807 000	492 000
Total Fiancial Fixed Assets	605 000	605 000	605 000	505 000
Total Fixed Assets	2 385 000	2 274 000	2 141 000	1 648 000
Stock	17 602 000	23 451 000	14 036 000	8 576 000
Total Investments	0	0	0	0
Cash, Bank	11 403 000	16 587 000	8 971 000	8 455 000
Total Current Assets	42 100 000	57 463 000	57 116 000	37 629 000
Total Assets	44 484 000	59 737 000	59 257 000	39 277 000
Total Equity	26 112 000	25 259 000	22 012 000	17 120 000
Short-Term Group Debt	4 500 000	17 000 000	0	0
Total Long-Term Debt	0	0	0	0
Creditors	7 326 000	8 656 000	10 022 000	7 870 000
Unpaid Taxes	2 170 000	2 714 000	3 952 000	2 276 000
Dividends	0	0	0	0
Other Current Debt	4 119 000	5 121 000	21 813 000	11 827 000
Total Current Debt	18 372 000	34 477 000	37 245 000	22 157 000
Total Equity and Debt	44 484 000	59 737 000	59 257 000	39 277 000

Financial indicators	2022	2021	2020	2019
Return on Equity	16,71 %	65,35 %	86,01 %	39,17 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	5,36 %	17,33 %	19,51 %	8,74 %
Current Ratio	2,29	1,67	1,53	1,7
Quick Ratio	54,68	5,21	2,46	2,77
Equity Ratio	0,59	0,42	0,37	0,44
Gross Profit Margin	36,57 %	42,27 %	41,7 %	35,59 %